Literature DB >> 16849742

Leuprolide acetate plus aromatase inhibition for male breast cancer.

Sharon H Giordano, Gabriel N Hortobagyi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849742     DOI: 10.1200/JCO.2006.07.2397

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors.

Authors:  Claudia Bighin; Gianluigi Lunardi; Lucia Del Mastro; Paola Marroni; Paola Taveggia; Alessia Levaggi; Sara Giraudi; Paolo Pronzato
Journal:  Oncologist       Date:  2010-12-08

2.  Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival.

Authors:  Linda C Harlan; Jo Anne Zujewski; Marc T Goodman; Jennifer L Stevens
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

Review 3.  [Male breast cancer: a challenge for urologists].

Authors:  C Hofer; B Schmalfeldt; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

4.  Multidisciplinary meeting on male breast cancer: summary and research recommendations.

Authors:  Larissa A Korde; Jo Anne Zujewski; Leah Kamin; Sharon Giordano; Susan Domchek; William F Anderson; John M S Bartlett; Karen Gelmon; Zeina Nahleh; Jonas Bergh; Bruno Cutuli; Giancarlo Pruneri; Worta McCaskill-Stevens; Julie Gralow; Gabriel Hortobagyi; Fatima Cardoso
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

5.  Male Breast Cancer.

Authors:  Christian Rudlowski
Journal:  Breast Care (Basel)       Date:  2008-06-24       Impact factor: 2.860

Review 6.  Male breast cancer: an update in diagnosis, treatment and molecular profiling.

Authors:  Susan Onami; Melanie Ozaki; Joanne E Mortimer; Sumanta Kumar Pal
Journal:  Maturitas       Date:  2010-02-06       Impact factor: 4.342

Review 7.  National consensus in China on diagnosis and treatment of patients with advanced breast cancer.

Authors:  Binghe Xu; Xichun Hu; Zefei Jiang; Huiping Li; Jiayi Chen; Shude Cui; Qing Li; Ning Liao; Donggeng Liu; Jian Liu; Jinsong Lu; Kunwei Shen; Tao Sun; Yuee Teng; Zhongsheng Tong; Shulian Wang; Xiang Wang; Xiaojia Wang; Yongsheng Wang; Jiong Wu; Peng Yuan; Pin Zhang; Qingyuan Zhang; Hong Zheng; Da Pang; Guosheng Ren; Zhimin Shao; Zhenzhou Shen; Erwei Song; Santai Song
Journal:  Ann Transl Med       Date:  2015-10

Review 8.  Male breast carcinoma: increased awareness needed.

Authors:  Jonathan White; Olive Kearins; David Dodwell; Kieran Horgan; Andrew M Hanby; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2011-09-29       Impact factor: 6.466

9.  Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.

Authors:  F Zagouri; T N Sergentanis; V Koutoulidis; C Sparber; G G Steger; P Dubsky; G C Zografos; T Psaltopoulou; M Gnant; M-A Dimopoulos; R Bartsch
Journal:  Br J Cancer       Date:  2013-05-30       Impact factor: 7.640

10.  Bilateral male breast cancer with male potential hypogonadism.

Authors:  Yukiko Hirose; Mitsunori Sasa; Yoshimi Bando; Toshiyuki Hirose; Tadaoki Morimoto; Yasushi Kurokawa; Taeko Nagao; Akira Tangoku
Journal:  World J Surg Oncol       Date:  2007-06-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.